Biggest News Aggregation in the World
📰 Robert Iannone News

Robert Iannone News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Robert Iannone. Real-time updates on events, politics, business and more.

European Commission Approves Rylaze for ALL and Lymphoblastic Lymphoma

The European Commission has granted marketing authorization for Rylaze for use as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia and lymphoblastic lymphoma in adult and pediatric patients 1 month and older who developed hypersensitivity or silent inactivation to E. coli–derived asparaginase.
Carmelo Rizzari Robert Iannone University Of Milano Jazz Pharmaceuticals European Union European Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze® (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

DUBLIN, Sept. 21, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc today announced that the European Commission has granted marketing authorization for Enrylaze® for use as a component of a...
United States Carmelo Rizzari Andrean Flynn Kristin Bhavnani Robert Iannone Children Oncology Group

Autolus Therapeutics plc (NASDAQ:AUTL) Q2 2023 Earnings Call Transcript

Autolus Therapeutics plc (NASDAQ:AUTL) Q2 2023 Earnings Call Transcript August 6, 2023 Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Second Quarter 2023 Financial Results Conference. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that […]
United Kingdom United States Robert Iannone Lucinda Crabtree Noah Burhance Rob Dolski
Source: yahoo.com

JZP458 Receives CHMP Recommendation for Approval in ALL, Lymphoblastic Lymphoma

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the approval of JZP458 for use in combination with multi-agent chemotherapy for the treatment of adult and pediatric patients 1 month and older with acute lymphoblastic leukemia and lymphoblastic lymphoma who developed hypersensitivity or silent inactivation to Escherichia coli–derived asparaginase.
United States Robert Iannone European Union Jazz Pharmaceuticals European Commission European Medicines Agency

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science